Gene: PABPC4L
Official Full Name: poly(A) binding protein cytoplasmic 4 likeprovided by HGNC
Gene Summary: Predicted to enable mRNA 3'-UTR binding activity; poly(A) binding activity; and poly(U) RNA binding activity. Predicted to be part of ribonucleoprotein complex. Predicted to be active in cytoplasmic stress granule; cytosol; and nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO26517 | PABPC4L Knockout cell line (HeLa) | Human | PABPC4L | 1:3~1:6 | Negative | Online Inquiry |
KO26518 | PABPC4L Knockout cell line (HEK293) | Human | PABPC4L | 1:3~1:6 | Negative | Online Inquiry |
PABPC4L Gene Knockout Cell Lines are specialized cellular models engineered to have the PABPC4L gene completely knocked out, thereby providing researchers with a powerful tool to explore the biological functions and regulatory mechanisms associated with this gene. These cell lines serve as pivotal resources for understanding mRNA metabolism, protein synthesis, and the overall role of poly(A)-binding proteins in cellular processes.
The primary function of PABPC4L involves its participation in the stabilization of mRNA and regulation of translation, impacting gene expression at multiple levels. By utilizing these knockout cell lines, researchers can dissect the specific contributions of PABPC4L to critical cellular pathways, enabling detailed studies on mRNA decay, translational control, and stress response mechanisms. This, in turn, allows for the exploration of potential pathological conditions linked to aberrant PABPC4L function.
Scientifically, these cell lines hold immense value in both research and clinical settings. They can illuminate the roles of poly(A)-binding proteins in various diseases, including cancer, neurodegenerative disorders, and metabolic syndromes. By revealing the underlying molecular mechanisms of such conditions, this research can potentially lead to the development of novel therapeutic strategies.
Unlike traditional cell lines, PABPC4L Gene Knockout Cell Lines offer distinct advantages, including the ability to study gene function without compensatory mechanisms that might obscure results in wild-type or partially knocked down cells. This specificity empowers researchers to achieve more reliable and reproducible data.
For researchers and clinicians dedicated to advancing their understanding of genetic regulation and its implications in health and disease, PABPC4L Gene Knockout Cell Lines represent a crucial asset. They provide an unparalleled opportunity for innovation in experimental design and therapeutic discovery.
Our company stands at the forefront of biotechnological advancements, specializing in the development of high-quality genetic models that empower scientific inquiry. With expertise in gene editing technologies and a commitment to providing reliable biological products, we are dedicated to supporting your groundbreaking research efforts.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.